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tion due to a reduction of some repolarizing K+ currents and an increase of the L-type calcium current. Experi-
mental and clinical works call into question the unique role of T3 and T4 in these mechanisms and correlate
increased serum TSH levels with the repolarization abnormalities in patients with both subclinical and overt hy-
pothyroidism. In this context, the aim of the present study was to investigate the direct effects of TSH upon car-
diac electrical properties.
Methods: The action potential recording and the ion channel subunits mRNA expression were obtained from left
ventricle of adult rats. Additionally, the repolarizing K+ currents and the L-type Ca2+ current (ICa-L) were re-
corded in isolated rat adult ventricular myocytes by the patch-clamp technique.
Results: 24 h exposure to TSH lengthened the action potential and slightly depolarized the restingmembrane po-
tential. TSH- receptor activation causes a reduction of the amplitude of Ito and IK1 currents caused by a reduction
in channels expression. However, TSH had no effect on ICa-L, IK or IKur.
Conclusion: These results support the idea that some of the electrical disturbances seen in hypothyroid hearts,
such as the Ito and IK1 current reduction, could be caused not by low T3 but by the elevation of circulating TSH.
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
In the western countries, almost half of the visits to the endocrinol-
ogist are related to thyroid dysfunctions. Symptoms speciﬁcally related
to heart activity are poor exercise tolerance and increased fatigability
[1]. In later stages ventricular ﬁbrosis, myocardial edema and reduced
cardiac output can be found [2,3,4]. The electrocardiogram of hypothy-
roid patients shows a series of abnormalitieswhich include sinus brady-
cardia and cardiac repolarization alterations such as prolonged QT and
QTc intervals and higher QT dispersion [3,5,6]. Due to the well-
established correlation between repolarization abnormalities and cardi-
ac arrhythmias, the identiﬁcation of the underlying molecular mecha-
nisms is a matter of great interest. Prolonged repolarization time canlogía, Facultad de Farmacia,
06 Vitoria-Gasteiz, Spain.
. This is an open access article underbe caused by an increase of the depolarizing currents or to a decrease
of repolarizing currents. In this sense, several works demonstrated
that hypothyroidism reduces some cardiac repolarizing K+ currents
such as the transient outward potassium current (Ito)whereas increases
the L-type calcium current (ICa-L) [7,8,9,10].
However, previous studies have demonstrated that i) thyroid hor-
mone has no effect on Ito current density in adult cardiac myocytes; ii)
patients with subclinical hypothyroidism, where T3 and T4 levels are
not reduced, share most of the cardiac repolarization abnormalities
with overt hypothyroidism [6,11,12]; and iii) several works correlated
elevated serum Thyroid Stimulating Hormone (TSH) levels with the re-
polarization abnormalities in patients with subclinical and overt hypo-
thyroidism [5,11]. Taken together, these experimental and clinical
works call into question the unique role of low T3 and T4 levels in
thesemechanisms, but to date the possible effects of TSH on the cardiac
electrical activity has not been explored.
Thus, in the present work we analyzed the direct effects of either
acute or 24 h exposure to TSH on the cardiac electrophysiologicalthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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not affect the properties of the L-type calcium current, it directly modu-
lates cardiac action potential duration, and therefore electrical activity,
through the regulation of the expression of two potassium currents:
the transient outward and the inward rectiﬁer (IK1).
2. Materials and methods
The investigation fulﬁlls the Spanish (RD1201/2005) and European
(D2003/65/CE and R2007/526/CE) Guidelines for the Care of Animals
Used in Experimental and other Research Purposes, and has been ap-
proved by the Ethics Committee for Animal Care of the Universidad
del País Vasco (CEBA/46/2010).
2.1. Membrane potential recording
Young adult Sprague–Dawley rats were anesthetized by intraperito-
neal injection of chloral hydrate (3 ml/kg). The hearts were removed
and perfused with a KB solution (in mmol/l): taurine 10, glutamic acid
70, creatine 0.5, succinic acid 5, dextrose 10, KH2PO4 10, KCl 20,
HEPES-K+ 10, EGTA-K+ 0.2, adjusted to pH 7.4 with KOH. TSH 30 mU/L
or vehiclewas added to the KB solution to ensure the correct distribution
of the drug through the heart. Then epicardialmuscle stripswere dissect-
ed and incubated in KB solutionwith or without TSH 30mU/L for 24 h at
4 °C. After incubation, the tissue was pinned to the bottom of a tissue
bath in order to expose the epicardial side. The preparations were
superfused with Tyrode's solution (in mM): NaCl 150, KCl 5.4, CaCl2
1.8, MgCl2 1.0, D-glucose 11.0, HEPES 10.0, pH 7.4 adjusted with NaOH.
Superfusionwas performed at 37 °C saturatedwith pure oxygen at a con-
stant ﬂow of 5 ml/min (Gilson Minipuls 3). The tissue was stimulated at
four different basic cycle lengths (1000ms, 800ms, 500ms and 300ms).
Transmembrane potential was recorded using glass microelectrodes
(10–40 MΩ DC resistance) ﬁlled with 2.7 M KCl, connected to a high
input impedance microelectrode ampliﬁer (Electro 705, World Precision
Instruments, USA). Ampliﬁed signals were digitized (1440 Digidata A/D
interface, Axon Instrument, Inc.) and stored in a computer for laterFig. 1. TSH prolongs ventricular action potential duration. (A) Ventricular action potentials reco
and TSH30mU/L. (B) Action potential duration at 30 and 90% of repolarization (APD30 andAPD
symbols) or with TSH (ﬁlled symbols). *p b 0.05; **p b 0.01, n = 11 cells from 3 to 5 hearts peanalysis using the software LabChart 7.3 (AD Instruments, Australia).
The following action potential (AP) parameters were analyzed:
maximum diastolic potential, AP amplitude (APA) and AP duration at
30 and 90% of repolarization (APD30 and APD90, respectively). The
maximum negative slope was calculated by linear regression as the
steepest downhill slope starting 5ms after theAP peak during awindow
of 4 ms. The AP triangulation was calculated by subtracting APD30 from
APD90.
2.2. Cardiomyocyte isolation
Animals were anesthetized by intraperitoneal injection of chloral
hydrate (3 ml/kg). The hearts were removed and perfused at 37 °C
with: 1) a Tyrode solution containing (in mmol/l): NaCl 118, KCl 5.4,
NaHCO3 24, MgCl2 1.02, CaCl2 1.8, NaH2PO4 0.42, dextrose 12 and tau-
rine 20, bubbled with 95% O2 and 5% CO2, pH 7.4 at 37 °C, 2) the same
solution without Ca+2, and 3) the nominally Ca2+-free solution con-
taining collagenase Type I (0.5 mg/ml; CDU ≥ 125 units/mg) and prote-
ase Type XIV (0.03 mg/ml; activity ≥3.5 units/mg) and 4) the KB
solution. Last, the epicardium of the left ventricle was excised and
cardiomyocytes were obtained bymechanical agitation of the ventricle.
Aliquots of the KB solution containing themyocyte suspension were in-
cubated for 24 h at 4 °C with TSH or vehicle. In one set of experiments
the myocytes were incubated for 2 h with the anti-TSHR antibody
(Santa Cruz Biotechnology) and then TSH for 24 h.
2.3. Patch-clamp recordings
Isolated myocytes were transferred to a shallow chamber and
allowed to settle for at least 10minbefore being superfusedwith the ex-
ternal bathing solution. For the experiments we used only Ca2+-
tolerant rod-shaped cells, with clear cross-striations and lacking any
visible blebs on their surfaces. All experiments were performed at
room temperature (20–22 °C).
Ionic currents were recorded using the whole-cell conﬁguration of
the Patch-Clamp technique with an Axopatch 200B patch-clamprded in epicardial strips from the same heart after 24 h incubation with vehicle (control)
90 respectively) at different basic cycle lengths (BCL), after 24 h incubation in control (open
r group. In this and subsequent ﬁgures the dashed line indicates the zero level.
Fig. 2. TSH does not alter Ca2+ currents in ventricular myocytes. (A) superimposed ICa-L
currents recorded at +10 mV in ventricular myocytes incubated 24 h in control or with
TSH 30 mU/L. B) 24 h incubation with TSH (ﬁlled symbols; n = 9 cells from 4 different
hearts) has no effect on ICa-L density at any voltage studied when compared to control
cells (open symbols; n = 12 cells from 4 different hearts). C) mRNA levels of Cav1.2 in
myocardial preparations is similar in control (white) and TSH treated cells (black). N =
6 hearts.
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from borosilicate tubes (Sutter Instruments) and had a tip resis-
tance of 1–3 MΩ when ﬁlled with the internal solution (in mmol/l):
L-aspartic acid (potassium salt) 80, KH2PO4 10, MgSO4 1, KCl 50,
HEPES-K+ 5, ATP-Na2 3, EGTA-K+ 10, adjusted to pH 7.2 with KOH.
Following the patch rupture, whole cell membrane capacitances
were measured from integration of the capacitive transients elicited
by voltage steps from −50 to −60 mV, which did not activate any
timedependentmembrane current. Series resistanceswere compensat-
ed 80% in order to minimize voltage errors.
Recordings of Ito and IKur potassium currents were made using the
following external bathing solution (in mmol/l): NaCl 86, MgCl2 1,HEPES-Na+10, KCl 4, CaCl2 0.5, CoCl2 2, dextrose 11, TEA-Cl 50, adjusted
to pH 7.4 with NaOH. Voltage pulses ranging from −30 to +50 mV,
starting from a holding potential of−60mVwere applied at a frequen-
cy of 0.1 Hz to ensure the full recovery of Ito from inactivation.
The bathing solution for IK1 current recordings was (in mmol/l):
NaCl 136, MgCl2 1, HEPES-Na+ 10, KCl 4, CaCl2 0.5, CoCl2 2, dextrose
11, adjusted to pH 7.4 with NaOH. Voltage pulses ranged from−110
to−30mVand started from a 40msprepulse to−40mV. The same so-
lution supplemented with 4-Aminopiridine 4 mM was used for IK cur-
rent recording. Starting from a 40 ms prepulse to −40 mV, voltage
pulses ranged from−30 to +50 mV.
For ICa-L calcium current recording the external bathing solution
was (in mmol/l): NaCl 86, MgCl2 1, HEPES-Na+ 10, KCl 4, CaCl2 1.8,
TEA-Cl 50, 4-Aminoprirydine 4, dextrose 11, adjusted to pH 7.4 with
NaOH. The voltage protocol was the same as for IK recordings.
All voltage pulses were applied at a frequency of 0.1 Hz. The voltage-
clamp experimental protocols were controlled with the “Clampex” pro-
gram and current recordings were analyzed with the “Clampﬁt” pro-
gram of the “pClamp 10.2” software (Axon Instruments Inc.). Current
amplitudes were normalized to cell capacitance, and expressed as
pA/pF.
2.4. qRT-PCR
The levels ofmRNA expression of Kv4.2, Kv4.3, KChIP2, Kv1.5, Kv2.1,
Kir 2.1 and Cav1.2 genes in left ventricular cardiac stripsweremeasured
by quantitative real-time RT-PCR (qRT-PCR). Following 24 h incubation
with KB solution with or without TSH (30mU/L) total RNAwas extract-
ed from10mgof frozenmuscle pieces and treatedwithDNase using the
RNeasy® Fibrous Tissue Mini Kit (Qiagen, USA), following the
manufacturer's instructions. The concentration of total RNA in each
sample was measured spectrophotometrically using NanoDrop 2000
(Thermo Scientiﬁc, USA). Next, 1 μg of total RNA was reversely-
transcribed into cDNA using random primers and the High Capacity Re-
verse Transcription Kit (Applied Biosystems, USA), according to the
manufacturer's instructions. The reactions were carried out in the PTC-
100 Programmable Thermal Controller (MJ Research). The ampliﬁcation
programwas25 °C for 10min, 37 °C for 120min, 85 °C for 5min and 4 °C
for 10 min.
Determinationswere performed in 96-well plates in a 15 μl ﬁnal vol-
ume containing 2 μl of 10× diluted of KChIP2, Kv4.2, Kv4.3, Kv1.5, Kv2.1,
Kir2.1 and Cav1.2 cDNA stock, 7.5 μl of Power SYBRMasterMix (Applied
Biosystems) and 150 nM of each forward and reverse of KChIP2, Kv4.2,
Kv4.3, Kir2.1, Kv2.1, Kv1.5 and Cav1.2 primers, (see online Supplemen-
tal material Table S1). The ampliﬁcation program was 55 °C for 2 min,
95 °C for 10 min followed by 40 cycles of 95 °C for 30 s and 60 °C for
1min. Each cDNAwas ampliﬁed in duplicate and a corresponding sample
without reverse transcriptase (no-RT sample) was included as negative
control. In addition, the expression of the chosen genes was normalized
to that of GAPDH as an internal control. The relative quantities of gene-
speciﬁc mRNA expression were determined by the comparative Ct
method expressed by the formula 2−(ΔCt), where Ct refers to the “thresh-
old cycle” and is determined for each plate by the ViiA™ 7 Real-Time PCR
System (Applied Biosystems).ΔCt is the Ct of the targetmRNAminus the
Ct of the endogenous control (GAPDH). ΔΔCt of LPS group is deﬁned as
the difference between ΔCt of treated group and the mean of control
group ΔCt. The fold-change in the expression of the target genes was
calculated as mean ± standard deviation of 2−(ΔCt) for the control and
TSH groups [13].
2.5. Statistical analysis
Data are presented as mean ± SEM. Comparisons between groups
were performed using Student's t test, or one-way analysis of variance,
followed by a Bonferroni multiple comparison test. Values of p b 0.05
Fig. 3. The activation of the TSH-receptor reduces the Ito K+ current in ventricular myocytes. (A) Superimposed Ito currents recorded at +50mV in ventricularmyocytes incubated 24 h in
absence and presence of TSH30mU/L. (B) Curent–voltage relationship obtained inmyocytes incubated 24hwith vehicle (open circles) or TSH10mU/L (ﬁlled squares) and 30mU/L (ﬁlled
triangles). C) Curent–voltage relationship obtained in myocytes incubated 24 h with vehicle (open circles) or TSH 30 mU/L in the presence of an anti TSH-receptor (ﬁlled squares).
D) mRNA expression of Kv4.3, Kv4.2 and KChIP2 in myocardial preparations incubated for 24 h in the absence (white) and presence (black) of TSH 30 mU/L. *p b 0.05; **p b 0.01;
n = 12–17 cells from 3 to 8 hearts.
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GraphPad Prism 5.0 (GraphPad Software, USA).
3. Results
To investigate the acute effect of the Thyroid Stimulating Hormone
on the cardiac electrical activity, we recorded ECG on isolated rat hearts
that were perfused for 30 min with TSH (30 mU/L) containing solution.
This short incubation did not modify the ECG parameters (Supplemen-
tary material, Fig. S1). Moreover, we recorded the Ito current, the main
repolarizing current in the rat ventricle, upon 30 min of TSH incubation
and found no changes on the either in Ito current density or biophysical
properties (Supplementary material, Fig. S2).
Since the acute effect of the hormone could be ruled out, we focused
on longer exposure and performed the rest of the experiments after
24 h incubation. In rat left ventricular strips, we found that TSH incuba-
tion lengthened the action potential at 30 and 90% of repolarization
(Fig. 1A). As shown in Fig. 1B, the effect was not dependent on the fre-
quency of stimulation. Additionally, TSH incubation prolonged the tri-
angulation of the AP while decreased the maximal negative slope of
repolarization (Supplementary material, Table S2). Interestingly, the
maximumdiastolic potentialwas slightly depolarized inmyocytes incu-
bated with TSH when compared to control cells (−75 ± 1.5 vs−70 ±
1.5 respectively, p b 0.05). It must be noted that all the control and TSH
treated action potentials show low amplitude and overshoot, probably
due to the 24h incubation and could be considered as a study limitation.
In order to identify the underlying mechanisms for the changes in
action potential parameters, we ﬁrst studied the effects of TSH on the
two main ionic currents responsible for the action potential duration
in rat: the L-type calciumand the transient outwardpotassiumcurrents.
First, incubation of isolated epicardial ventricularmyocyteswith TSH
did not modify the cell capacitance (98.8 ± 7 vs 98.1 ± 7.1 in controland TSH respectively, n = 31–32 cells from 11 to 18 hearts). Thus, the
possible changes in current densities could not be attributed to cell
hypertrophy.
In epicardial ventricular myocytes 24 h exposure to TSH had no ef-
fect on ICa-L current density and did not modify Cav1.2 mRNA channels
expression (Fig. 2). Therefore, a decrease in the K+ currents is the most
likely mechanism responsible for the APD prolongation.
In fact, incubation of cardiomyocytes with TSH reduced Ito current
density almost to 50% and in a concentration-dependent manner
(Fig. 3A, B). We tested 10 and 30 mU/L of TSH because these are the
serum levels usually found in patients with subclinical and overt hypo-
thyroidism respectively [6,11]. No effect was observed on the biophysi-
cal parameters of the current (Supplementary material, Table S3).
We wanted to identify the mechanisms responsible for the TSH-
induced reduction in Ito current density and theﬁrst stepwas to conﬁrm
that it requires the activation of the TSH-receptor. Thus, we incubated
the ventricular myocytes with TSH in the presence of an antibody
against the TSH receptor. We found that when the receptor is blocked
TSH failed to induce any change in the Ito current (Fig. 3C).
Since the effect of TSH on the Ito current speciﬁcally concerns current
density and it is observed after long but not acute incubation times, it
could be due to a reduction of the channel forming proteins. As expect-
ed, qRT-PCR experiments showed a reduction in the expression of the
RNA encoding the pore forming proteins Kv4.2 and Kv4.3 and the acces-
sory protein KChIP2 (Fig. 3D).
Even though that Ito is the main rat potassium repolarizing current,
other potassium currents could contribute to determine the AP dura-
tion. Therefore, we explored the effect of TSH on the ultrarapid delayed
rectiﬁer Ikur and the delayed rectiﬁer Ik in rat ventricular
cardiomyocytes. Thus, 24 h incubation with TSH 30 mU/L did not mod-
ify either IK or IKur current amplitudes (Fig. 4A, B). Accordingly, Kv2.1 or
Kv1.5 channels mRNA expression was also not modiﬁed.
Fig. 4. TSH does not alter delayed rectiﬁer K+ currents in ventricular myocytes. (A) Superimposed IK and IKur currents recorded at +50mV in ventricular myocytes incubated 24 h in ab-
sence and presence of TSH 30mU/L. (B) Curent–voltage relationship obtained inmyocytes incubated 24 hwith vehicle (open symbols) or TSH 30mU/L (ﬁlled symbols). C)mRNA expres-
sion of Kv2.1 and Kv1.5 in myocardial preparations incubated for 24 h in the absence (white) and presence (black) of TSH 30 mU/L. n = 5–8 cells from 4 to 6 hearts.
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brane potential was observed after 24 h exposure to TSH when com-
pared to control condition, the inward rectiﬁer IK1 current density was
also explored in cardiomyocytes incubated with TSH. Interestingly,
TSH exposure clearly reduced the density of the inward rectiﬁer current
IK1 as well as the mRNA expression of the Kir2.1 channel (Fig. 5).4. Discussion
Hypothyroidism impairs cardiac repolarization, as observed in ECG
and action potentials of hypothyroid patients and experimental animal
models. Most of the repolarization abnormalities found in hypothyroid-
ism are secondary to a reduction of the Ito, and an increase in the ICa-L [9,
10,12].
It was previously described that the ICa-L calcium current is regulat-
ed by T3 at transcriptional and posttranscriptional level. The Cav1.2
channel expression is reduced by the thyroid hormone and the calcium
current is also modulated by T3 through cAMP [9,14]. However, al-
though thyroid hormones are needed for the normal Ito development
in neonatal cardiac myocytes [7,15,16], the lack of effect of T3 on Ito in
both healthy and hypothyroid adult cardiac myocytes was also consis-
tently reported [12,16]. Thus, the T3 reduction in hypothyroid status
could explain the increase in ICa-L, but not the reduction of Ito.
In the last decade, several clinical groups correlated serum TSH
levels with the repolarization abnormalities [5,11]. This correlation is
also supported by the fact that subclinical hypothyroidism, with normalT3 and T4 levels but elevated TSH, share most of the cardiac repolariza-
tion abnormalities with overt hypothyroidism [6,11].
In the present work, we demonstrate that TSH has no acute effects
on cardiacmyocytes, but long lasting exposure to the hormoneprolongs
action potential. This could be caused by an increase in the depolarizing
Ca2+ current and/or a decrease in the repolarizingK+ currents. Since in-
cubation of epicardial ventricular myocytes with TSH did not affect the
ICa-L current density or Cav1.2 mRNA channels expression, a decrease
in the K+ currents is the most likely mechanism responsible for the
APD prolongation. In this sense, the observed lengthening in APD30
and the fact that it is not frequency dependent makes Ito, the current
that drives the AP phase 1 the main candidate. Consistent with that,
we found that exposure to TSH reduces the Ito current amplitude in
adult ventricular myocytes. This reduction of the potassium current is
not caused by biophysical dysfunctions but to a decrease in channel
mRNA expression. Conversely, IK and IKur currents were not affected
by TSH. In addition, the reduction in the Kir2.1 mRNA and IK1 current
density could explain the resting potential depolarization observed
after TSH incubation.
TSH receptors (TSH-R) are present in thyroid follicular cells because
these are themain TSH target. These receptors have also been described
in adipocytes, hepatocytes, lymphocytes and ﬁbroblasts [17,18,19,20].
However, the expression of TSH-R in the heart has been somehow con-
troversial. Although two independent groups detected the presence of
TSH-R mRNA [21,22], other group failed to localize TSH-R [23] in the
heart. The matter was settled in an elegant paper published by Huang
et al. that demonstrated, by different techniques, the functional
Fig. 5. TSH reduces the IK1 K+ current in ventricular myocytes. (A) Superimposed IK1 cur-
rents recorded at−100 mV in ventricular myocytes incubated 24 h in absence and pres-
ence of TSH 30 mU/L. (B) Curent–voltage relationship obtained in myocytes incubated
24 h with vehicle (open symbols) or TSH 30 mU/L (ﬁlled symbols). C) mRNA expression
of Kir2.1 in myocardial preparations incubated for 24 h in the absence (white) and pres-
ence (black) of TSH 30 mU/L. *p b 0.05; n = 5–8 cells from 4 to 6 hearts.
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support their ﬁnding that TSH-R is active in ventricular myocytes,
since the reduction of the transient outward potassium current density
by TSH is blunted by TSH-R blockade.
In the human heart, the main repolarizing currents are the K+ cur-
rents: the transient outward Ito, the rapid delayed rectiﬁer IKr, and the
inward rectiﬁer IK1 in the ventricles and the ultrarapid delayed rectiﬁer
IKur in the atria. These currents are generated by the K+ ﬂux across the
Kv4.3; Kv11.1 or HERG; Kv1.5 and Kir2.1 channels respectively [25,26,
27,28,29]. However, rat ventricular cells lack the human IKr and have in-
stead a non-human-like delayed rectiﬁer IK, carried through Kv2.1 chan-
nels. Thus, one limitation of the present study is that the Ito and IK1
current reductions could not have the same impact on QT interval dura-
tion in humans.The present results indicate a transcriptional regulation of the tran-
sient outward and the inward rectiﬁer potassium currents by the activa-
tion of the TSH receptors in cardiac myocytes. Previous works support
the idea that some of the electrical abnormalities seen in hypothyroid
hearts, such as the increase in ICa-L, are due to the reduction of T3 levels.
Interestingly, our data introduces for the ﬁrst time evidence that chang-
es in the concentration of other hormone, such as TSH elevation, could
also be involved in the mechanism of hypothyroidism-induced cardiac
electrical disturbances.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.yjmcc.2015.10.019.
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